Generate a tailored SOP for Dr. Ashlee Brunaugh. Improve your application with a focused, well-structured draft.
Ashlee Brunaugh is an Assistant Professor in the Department of Pharmaceutical Sciences at the University of Michigan. She completed her PhD in Pharmaceutical Sciences at the University of Texas at Austin in 2020, following her PharmD at the same institution in 2016. Her professional experience includes serving as the President and CEO of CloXero Therapeutics Inc since 2020 and holding several key positions at Therapeutics LLC from 2018-2021, where she was Senior Research Scientist and Director of Strategy Operations. Dr. Brunaugh's research is primarily focused on respiratory diseases, which are a major cause of global morbidity and mortality. Her work investigates the complex pathology underlying chronic lung diseases, addressing factors such as the lung microbiome, airway architecture, and immune responses to opportunistic infections. The Brunaugh Lab aims to develop novel inhaled drug delivery approaches to improve patient outcomes through elucidation of respiratory disease mechanisms and targeting appropriate therapeutic interventions.
University of Michigan • Ann Arbor, MI
Teaching and conducting research in the Department of Pharmaceutical Sciences.
CloXero Therapeutics Inc • Austin, TX
Leading strategic initiatives and operations of the company.
Therapeutics LLC • Austin, TX
Oversaw the strategic operations of an organization focused on therapeutics.
Therapeutics LLC • Austin, TX
Conducted research and development in therapeutic solutions.
Department of Electrical Engineering and Computer Science